[membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
FDA and Health Canada regulators will hold a joint public consultation on ICH documents currently under development to obtain stakeholder feedback on May 6, 2016, 9am-12 pm, at FDA’s White Oak campus in Silver Spring, Maryland. The meeting will be held under the auspices of the Canada-U.S. Regulatory Cooperation Council (RCC), which was created in February 2011 to better align the two countries’ regulatory approaches. The agencies will be seeking feedback on several ICH documents to gather feedback for the next ICH face-to-face meeting in June 2016 in Lisbon, Portugal. Future meetings will continue to alternate between Canada and the USA, with the next meeting – which is planned to be hosted by Health Canada – to occur in the fall of 2016 prior to the next scheduled ICH meeting.
[/membership]
INTERNATIONAL PHARMACEUTICAL QUALITY
Inside the Global Regulatory Dialogue
